All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

331

Reset

331 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • Meiji Seika Pharma Co., Ltd. · Complicated Urinary Tract Infection, Acute Pyelonephritis, Hospital-acquired Bacterial Pneumonia

  • Copper Cu 64 PSMA I&TPhase 32 trials

    Curium US LLC · Prostate Cancer, Prostate Adenocarcinoma, Biochemical Recurrence of Malignant Neoplasm of Prostate

  • CTX-009Phase 32 trials

    Compass Therapeutics · Biliary Tract Cancer, Cholangiocarcinoma, Gall Bladder Cancer

  • CyclosporinPhase 32 trials

    Shanghai JMT-Bio Inc. · Primary Membranous Nephropathy

  • DWP16001Phase 32 trials

    Daewoong Pharmaceutical Co. LTD. · Type 2 Diabetic Nephropathy, T2DM (Type 2 Diabetes Mellitus)

  • for organ preservation in transplantationCustodiol-N, CustodiolPhase 32 trials

    Dr. F. Köhler Chemie GmbH · Heart Transplantation, Kidney Failure, Liver Failure, Chronic

  • HRS-8427Phase 32 trials

    Jiangsu HengRui Medicine Co., Ltd. · Complicated Urinary Tract Infection(cUTI), Including Acute Pyelonephritis(AP), Hospital-acquired Bacterial Pneumonia (HABP), Ventilator-associated Bacterial Pneumonia (VABP)

  • iltamiocelAMDC-USRPhase 32 trials

    Cook MyoSite · Stress Urinary Incontinence, Fecal Incontinence

  • JADE101Phase 32 trials

    Jade Biosciences, Inc. · IgA Nephropathy (IgAN), IgA Nephropathy

  • JNJ-101556143Phase 32 trials

    Johnson & Johnson (Janssen) · Prostatic Neoplasms

  • nacubactamPhase 32 trials

    Meiji Seika Pharma Co., Ltd. · Complicated Urinary Tract Infection, Acute Pyelonephritis, Hospital-acquired Bacterial Pneumonia

  • Pathalys Pharma · Secondary Hyperparathyroidism, End-stage Kidney Disease (ESKD), End Stage Kidney Disease

  • PF-07248144Phase 32 trials

    Pfizer · Locally Advanced or Metastatic ER+ HER2- Breast Cancer, Locally Advanced or Metastatic Castration-resistant Prostate Cancer, Locally Advanced or Metastatic Non-small Cell Lung Cancer

  • QRX-3EseronatePhase 32 trials

    Ebima Clifford Okundaye · Chronic Kidney Diseases, Acute Kidney Injury, Kidney Failure

  • RezvilutamidePhase 32 trials

    Jiangsu HengRui Medicine Co., Ltd. · Prostate Cancer, Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

  • rilparencelRenal Autologous Cell Therapy, REACTPhase 32 trials

    Prokidney · Type 2 Diabetes Mellitus, Chronic Kidney Diseases, Type 1 Diabetes Mellitus

  • RoxadustatFG-4592, ASP1517Phase 32 trials

    Astellas · Chronic Kidney Disease, Renal Anemia, Myelodysplastic Syndromes

  • RVX000222apabetalone, RVX-208Phase 32 trials

    Resverlogix Corp · Post-Acute COVID-19 Syndrome, Kidney Failure, Chronic

  • SAL0120Phase 32 trials

    Shenzhen Salubris Pharmaceuticals Co., Ltd. · Chronic Kidney Disease, Uncontrolled Hypertension, Resistant Hypertension

  • SHR6508Phase 32 trials

    Shanghai Hengrui Pharmaceutical Co., Ltd. · Secondary Hyperparathyroidism, Secondary Hyperparathyroidism (SHPT) in Subjects With Chronic Kidney Disease (CKD) on Hemodialysis

  • TMPSMX, Trimethoprim-sulfamethoxazolePhase 32 trials

    Locus Biosciences · Urinary Tract Infections, Candidemia, Mycoses

  • TR115Phase 32 trials

    Tarapeutics Science Inc. · Ovarian Clear Cell Carcinoma, Endometrial Cancer, Stomach Cancer Recurrent

  • TS-172Phase 32 trials

    Taisho Pharmaceutical Co., Ltd. · Hyperphosphatemia Patients on Hemodialysis

  • VepugratinibLY3866288Phase 32 trials

    Eli Lilly · Urinary Bladder Neoplasms, Urologic Neoplasms, Receptor, Fibroblast Growth Factor, Type 3

  • VX-147Inaxaplin, IXPPhase 32 trials

    Vertex Pharmaceuticals · Proteinuric Kidney Disease

  • WS016Phase 32 trials

    Waterstone Pharmaceutical (Wuhan) Co., LTD. · Hyperkalemia

  • XaluritamigAMG 509Phase 32 trials

    Amgen · Metastatic Castration-resistant Prostate Cancer

  • ZimislecelFormerly known as STx-02, VX-880Phase 32 trials

    Vertex Pharmaceuticals · Type 1 Diabetes, Kidney Transplant, Diabetes Mellitus, Type 1

  • ZuberitamabPhase 32 trials

    BioRay Pharmaceutical Co., Ltd. · Primary Membranous Nephropathy

  • BCD-131pegdarbepoetin betaPhase 31 trial

    Biocad · Anemia, Chronic Kidney Disease, Chronic Kidney Disease Patients on Hemodialysis

  • BHV-1400Phase 31 trial

    Biohaven Therapeutics Ltd. · IgA Nephropathy

  • BMS-986365Phase 31 trial

    Bristol Myers Squibb · Metastatic Castration-resistant Prostate Cancer

  • DeutenzalutamidePhase 31 trial

    AstraZeneca · Metastatic Castration-resistant Prostate Cancer

  • DTT106Phase 31 trial

    EMS · Prostatic Hyperplasia, Benign, Erectile Dysfunction

  • FuzuloparibPhase 31 trial

    Jiangsu HengRui Medicine Co., Ltd. · Metastatic Castration-Resistant Prostate Cancer (mCRPC)

  • HRS-4357Phase 31 trial

    Jiangsu HengRui Medicine Co., Ltd. · PSMA-Positive Progressive Metastatic Castration-Resistant Prostate Cancer

  • iCM012Phase 31 trial

    iCoat Medical AB · Ischemia-reperfusion Injury, Kidney Transplant; Complications

  • JNJ-87189401Phase 31 trial

    Johnson & Johnson (Janssen) · Metastatic Castration-resistant Prostatic Neoplasms

  • Alpine Immune Sciences Inc, A Subsidiary of Vertex · Immunoglobulin A Nephropathy

  • N0728Phase 31 trial

    Eurofarma Laboratorios S.A. · Benign Prostatic Hyperplasia With Lower Urinary Tract Symptoms

  • NEMO-103Phase 31 trial

    Inventera Inc. · Rotator Cuff Tear, Labral Tear, Rotator Cuff Tendinosis

  • New of NiraparibPhase 31 trial

    Johnson & Johnson (Janssen) · Castration-Resistant Prostatic Cancer

  • QLG1080Phase 31 trial

    Qilu Pharmaceutical Co., Ltd. · Prostate Cancer

  • RinzimetostatORIC-944Phase 31 trial

    ORIC Pharmaceuticals · Metastatic Castration Resistant Prostate Cancer

  • SasanlimabPF-06801591Phase 31 trial

    Pfizer · Non-muscle Invasive Bladder Cancer

  • SC0062Phase 31 trial

    Biocity Biopharmaceutics Co., Ltd. · IgA Nephropathy (IgAN)

  • SefaxersenRO7434656Phase 31 trial

    Roche (Genentech) · Primary IgA Nephropathy

  • Relmada Therapeutics, Inc. · Bladder (Urothelial, Transitional Cell) Cancer, Bladder (Urothelial, Transitional Cell) Cancer Superficial (Non-Invasive), Urothelial Carcinoma Bladder

  • MK-4830Phase 210 trials

    Merck & Co. · Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma, Esophageal Squamous Cell Carcinoma

  • NM8074Phase 28 trials

    NovelMed Therapeutics · Paroxysmal Nocturnal Hemoglobinuria, Dermatomyositis, PNH - Paroxysmal Nocturnal Hemoglobinuria

NewerPage 3 of 7Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.